Lee K, Caglic I, Liao P, Kessler D, Guo C, Barrett T
Eur Radiol. 2024; .
PMID: 39609284
DOI: 10.1007/s00330-024-11233-1.
Li P, Ni P, Kombak F, Wolters E, Haines G, Si Q
Int J Clin Exp Pathol. 2024; 17(5):173-181.
PMID: 38859919
PMC: 11162608.
DOI: 10.62347/JHYY2053.
Li P, Haines G, Si Q, Baskovich B
Int J Clin Exp Pathol. 2024; 17(3):78-82.
PMID: 38577694
PMC: 10988092.
DOI: 10.62347/ZQCI9925.
Bello R, Willis-Powell L, James O, Sharma A, Marsh E, Ellis L
Cancers (Basel). 2023; 15(15).
PMID: 37568712
PMC: 10416874.
DOI: 10.3390/cancers15153897.
Nascimento-Goncalves E, Seixas F, Ferreira R, Oliveira P, Colaco B
Open Vet J. 2023; 13(6):782-793.
PMID: 37545707
PMC: 10399646.
DOI: 10.5455/OVJ.2023.v13.i6.13.
The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer.
Oseni S, Naar C, Pavlovic M, Asghar W, Hartmann J, Fields G
Cancers (Basel). 2023; 15(12).
PMID: 37370720
PMC: 10296711.
DOI: 10.3390/cancers15123110.
Single-cell RNA-Seq identifies factors necessary for the regenerative phenotype of prostate luminal epithelial progenitors.
Moline D, Zenner M, Burr A, Vellky J, Nonn L, Vander Griend D
Am J Clin Exp Urol. 2023; 10(6):425-439.
PMID: 36636696
PMC: 9831919.
The most effective but largely ignored target for prostate cancer early detection and intervention.
Man Y, Mannion C, Jewett A, Hsiao Y, Liu A, Semczuk A
J Cancer. 2022; 13(13):3463-3475.
PMID: 36313040
PMC: 9608211.
DOI: 10.7150/jca.72973.
Preclinical and Clinical Research Models of Prostate Cancer: A Brief Overview.
Basak D, Gregori L, Johora F, Deb S
Life (Basel). 2022; 12(10).
PMID: 36295041
PMC: 9605520.
DOI: 10.3390/life12101607.
Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer.
Pramanik S, Halder A, Mukherjee U, Kumar D, Dey Y, R M
Front Chem. 2022; 10:948217.
PMID: 36034650
PMC: 9411967.
DOI: 10.3389/fchem.2022.948217.
Urethra Sparing With Target Motion Mitigation in Dose-Escalated Extreme Hypofractionated Prostate Cancer Radiotherapy: 7-Year Results From a Phase II Study.
Greco C, Pares O, Pimentel N, Louro V, Nunes B, Kociolek J
Front Oncol. 2022; 12:863655.
PMID: 35433469
PMC: 9012148.
DOI: 10.3389/fonc.2022.863655.
Male Lower Urinary Tract Dysfunction: An Underrepresented Endpoint in Toxicology Research.
Peterson N, Vezina C
Toxics. 2022; 10(2).
PMID: 35202275
PMC: 8880407.
DOI: 10.3390/toxics10020089.
Targeting Mitochondrial Metabolism in Prostate Cancer with Triterpenoids.
Mamouni K, Kallifatidis G, Lokeshwar B
Int J Mol Sci. 2021; 22(5).
PMID: 33671107
PMC: 7957768.
DOI: 10.3390/ijms22052466.
The relationship between overactive bladder and prostate cancer: A scoping review.
Khan A, Crump R, Carlson K, Baverstock R
Can Urol Assoc J. 2021; 15(9):E501-E509.
PMID: 33591905
PMC: 8490099.
DOI: 10.5489/cuaj.7058.
Dietary Factors and Prostate Cancer Development, Progression, and Reduction.
Oczkowski M, Dziendzikowska K, Pasternak-Winiarska A, Wlodarek D, Gromadzka-Ostrowska J
Nutrients. 2021; 13(2).
PMID: 33546190
PMC: 7913227.
DOI: 10.3390/nu13020496.
Steroidogenesis in Peripheral and Transition Zones of Human Prostate Cancer Tissue.
Deb S, Chin M, Pham S, Adomat H, Hurtado-Coll A, Gleave M
Int J Mol Sci. 2021; 22(2).
PMID: 33418978
PMC: 7825320.
DOI: 10.3390/ijms22020487.
Curcuma oil ameliorates benign prostatic hyperplasia through suppression of the nuclear factor-kappa B signaling pathway in rats.
Wang S, Li Y, Li W, Zhang K, Yuan Z, Cai Y
J Ethnopharmacol. 2020; 279:113703.
PMID: 33340599
PMC: 9586842.
DOI: 10.1016/j.jep.2020.113703.
Cellular and Molecular Progression of Prostate Cancer: Models for Basic and Preclinical Research.
Saranyutanon S, Deshmukh S, Dasgupta S, Pai S, Singh S, Singh A
Cancers (Basel). 2020; 12(9).
PMID: 32957478
PMC: 7563251.
DOI: 10.3390/cancers12092651.
Protective effects of combination of Stauntonia hexaphylla and Cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5α- reductase type 2 and induced cell apoptosis.
Karunasagara S, Hong G, Jung D, Kim K, Cho K, Jung J
PLoS One. 2020; 15(8):e0236879.
PMID: 32790676
PMC: 7425886.
DOI: 10.1371/journal.pone.0236879.
Ultrasonographic Follow-up of the Multistep Protocol for Prostate Cancer Induction in Wistar Rats.
Faustino-Rocha A, Seixas F, Ferreira R, Silva J, Pires M, Fardilha M
In Vivo. 2020; 34(4):1797-1803.
PMID: 32606149
PMC: 7439876.
DOI: 10.21873/invivo.11974.